SCHEMBL8358168

SCHEMBL8358168

Cc1ccc(NC(=O)c2cccnc2)c2c1oc1ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
RAB9A P51151 3/20 0.56
MAPT P10636 3/20 0.56
NPC1 O15118 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
ALDH1A1 P00352 4/20 0.55
HPGD P15428 1/20 0.55
HSD17B10 Q99714 1/20 0.55
POLB P06746 2/20 0.51
LMNA P02545 1/20 0.51
CYP2C19 P33261 1/20 0.50
GFER P55789 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
ALOX15 P16050 1/20 0.49
HTT P42858 1/20 0.49
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14184301 0.88 ALDH1A1 (0.56) KDM4EMEN1KMT2ARAB9AMAPT
SCHEMBL5023295 0.86 MAPT (0.67) KDM4EMEN1KMT2ARAB9AMAPT
SCHEMBL2330387 0.76 ALDH1A1 (0.73) KDM4ERAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL5022653 0.73 MAPT (0.65) KDM4EMEN1KMT2ARAB9AMAPT
SCHEMBL14880185 0.73 CYP2C19 (0.67) KDM4EMEN1KMT2ARAB9AMAPT
SCHEMBL14364602 0.71 LMNA (0.59) KDM4EKMT2AMAPTNPC1SMN1; SMN2
SCHEMBL23565700 0.71 ROCK2 (0.62) KDM4ERAB9AMAPTNPC1SMN1; SMN2
SCHEMBL13966176 0.70 L3MBTL1 (0.64) KDM4ERAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL9678478 0.70 GAA (0.50) MEN1KMT2ARAB9AMAPTNPC1
SCHEMBL17318522 0.69 HDAC1 (0.70) MEN1KMT2ARAB9ACYP2C19GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554262-B1 NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LTD (IN) 2007-12-05 EP disclosed
WO-2004037805-A1 NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LTD. (US) 2004-05-06 WO disclosed